Lv11
20 积分 2025-07-10 加入
PT101: A Treg selective agonist IL-2 mutein therapy for autoimmunity
1小时前
待确认
Safety and pharmacokinetics of IBI112, an IL-23 monoclonal antibody, in Chinese healthy volunteers: a first-in-human phase 1 study
9个月前
已完结
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
11个月前
已完结
Structure-based decoupling of the pro- and anti-inflammatory functions of interleukin-10
1年前
已完结
Characterization of JNJ-79635322, a Novel BCMAxGPRC5DxCD3 T-Cell Redirecting Trispecific Antibody, for the Treatment of Multiple Myeloma
1年前
已完结
A first-in-human study of the fibroblast activation protein–targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors
1年前
已完结
皖公网安备34019202002308
